Linanext D 5mg/10mg Tablet 10s

Introduction to Linanext D 5mg/10mg Tablet 10s

Linanext D 5mg/10mg Tablet 10s is a medication in tablet form primarily used to manage type 2 diabetes. It combines two active ingredients, Dapagliflozin and Linagliptin, to help control blood sugar levels in adults.

Composition of Linanext D 5mg/10mg Tablet 10s

Linanext D 5mg/10mg Tablet 10s contains two main components: Dapagliflozin and Linagliptin. Dapagliflozin works by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, promoting glucose excretion through urine. Linagliptin inhibits the enzyme dipeptidyl peptidase-4 (DPP-4), enhancing insulin secretion and reducing glucagon levels.

Uses of Linanext D 5mg/10mg Tablet 10s

• Management of type 2 diabetes
• Reduction of hospitalization risk for heart failure in type 2 diabetes patients with cardiovascular disease
• Management of chronic kidney disease

Side effects of Linanext D 5mg/10mg Tablet 10s

• Increased urination
• Urinary tract infections
• Genital infections
• Stuffy or runny nose
• Sore throat
• Cough
• Hypoglycemia, especially when used with insulin or sulfonylureas

Precautions of Linanext D 5mg/10mg Tablet 10s

Patients with severe renal impairment, end-stage renal disease, or those on dialysis should not use Dapagliflozin. It also carries warnings for ketoacidosis and dehydration. Linagliptin is contraindicated in patients with a history of hypersensitivity reactions. Caution is advised for patients with a history of pancreatitis.

How to Take Linanext D 5mg/10mg Tablet 10s

Linanext D 5mg/10mg Tablet 10s should be taken orally once daily, with or without food, as prescribed by your doctor. It is important to take it at the same time each day to maintain consistent blood levels.

Conclusion of Linanext D 5mg/10mg Tablet 10s

Linanext D 5mg/10mg Tablet 10s, containing Dapagliflozin and Linagliptin, is a therapeutic option for managing type 2 diabetes, reducing heart failure hospitalization risk, and managing chronic kidney disease. It is manufactured to provide a comprehensive approach to diabetes management. Regular monitoring and communication with healthcare providers are essential for safe use.